Skip to main content
Fig. 1 | Trials

Fig. 1

From: VolumE maNagement Under body composition monitoring in critically ill patientS on CRRT: study protocol for a randomized controlled trial (VENUS trial)

Fig. 1

The overall study algorithm. After enrollment, InBody S10 (InBody®, Seoul, Korea) will be used to measure fluid status at 0, 1, 2, and 7 days after the initiation of the continuous renal replacement therapy (CRRT) in InBody S10-based fluid management group, but at 0 and 7 days in fluid management guided by a generally used quantification method. Abbreviations: AKI acute kidney injury, CRRT continuous renal replacement therapy, D0 the day of CRRT initiation, D1, 2 and 7 1, 2 and 7 days from the day of CRRT initiation, respectively

Back to article page